Business News
Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for amivantamab-vmjw to identify patients with inoperable or recurrent NSCLC harbouring EGFR exon 20 insertion mutations, Business News
In a significant development for precision oncology in Japan, Guardant Health Japan Corp. has received r...












